Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium

被引：60

作者：

Bhaskar, Sonu ^{[1
,2
,3
,4
,5
]}

Bradley, Sian ^{[1
,6
]}

Israeli-Korn, Simon ^{[1
,7
,8
]}

Menon, Bindu ^{[1
,9
]}

Chattu, Vijay Kumar ^{[1
,10
]}

Thomas, Pravin ^{[1
,11
]}

Chawla, Jasvinder ^{[1
,12
,13
]}

Kumar, Rajeev ^{[1
,14
,15
]}

Prandi, Paolo ^{[1
,16
]}

Ray, Daniel ^{[1
,17
,18
]}

Golla, Sailaja ^{[1
,19
]}

Surya, Nirmal ^{[1
,20
,21
]}

Yang, Harvey ^{[1
,22
,23
]}

Martinez, Sandra ^{[1
,24
]}

Ozgen, Mihriban Heval ^{[1
,25
,26
]}

Codrington, John ^{[1
,23
,27
]}

Jimenez Gonzalez, Eva Maria ^{[1
,28
]}

Toosi, Mandana ^{[1
,29
,30
]}

Mohan, Nithya Hariya ^{[1
,31
]}

Menon, Koravangattu Valsraj ^{[1
,32
]}

Chahidi, Abderrahmane ^{[1
,33
,34
,35
]}

Mederer Hengstl, Susana ^{[1
,36
]}

机构：

[1] Liverpool Hosp, Chron Neurol REPROGRAM Subcomm, Pandem Hlth Syst REsilience PROGRAM REPROGRAM Con, Sydney, NSW, Australia

[2] Liverpool Hosp, Dept Neurol & Neurophysiol, Sydney, NSW, Australia

[3] Ingham Inst Appl Med Res, Neurovasc Imaging Lab, Sydney, NSW, Australia

[4] Ingham Inst Appl Med Res, NSW Brain Clot Bank, Sydney, NSW, Australia

[5] Univ New South Wales, UNSW Med, South West Sydney Clin Sch, Sydney, NSW, Australia

[6] Univ New South Wales, UNSW Med, Sydney, NSW, Australia

[7] Sheba Med Ctr, Dept Neurol, Ramat Gan, Israel

[8] Tel Aviv Univ, Sackler Sch Med, Movement Disorders Inst, Tel Aviv, Israel

[9] Apollo Hosp, Dept Neurol, Nellore, India

[10] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON, Canada

[11] Univ Hosp NHS Fdn Trust, Dept Neurol, Birmingham, W Midlands, England

[12] Loyola Univ Med Ctr, Dept Neurol, Chicago, IL USA

[13] Hines VA Hosp, Chicago, IL USA

[14] Hamad Med Ctr, Dept Psychiat, Doha, Qatar

[15] Australian Natl Univ, Canberra, ACT, Australia

[16] Univ Eastern Piedmont Amedeo Avogadro, Dept Neurol, Novara, Italy

[17] UCL, Farr Inst Hlth Informat, London, England

[18] NHS Fdn Trust, Birmingham, W Midlands, England

[19] Texas Inst Neurol Disorders, Dallas, TX USA

[20] Bombay Hosp & Med Res Ctr, Dept Neurol, Mumbai, Maharashtra, India

[21] Epilepsy Fdn India, Mumbai, Maharashtra, India

[22] Acad Hosp Paramaribo, Dept Neurol, Paramaribo, Suriname

[23] Anton de Kom Univ Suriname Fac Med Wetenschappen, Paramaribo, Suriname

[24] Hosp Restauracao, Dept Neurol, Recife, PE, Brazil

[25] Parnassia Psychiat Inst, Dept Psychiat, The Hague, Netherlands

[26] Leiden Univ, Med Ctr, Curium, Oegstgeest, Netherlands

[27] Acad Hosp Paramaribo, Dept Lab Med, Paramaribo, Suriname

[28] Minist Justice, Dept Forens Psychol, Forens Psychol & Forens Sci Inst, Granada, Spain

[29] LodeStone Ctr Behav Hlth, Chicago, IL USA

[30] Eastern Illinois Univ, Chicago, IL USA

[31] Chengalpattu Med Coll & Hosp, Chengalpattu, India

[32] South London & Maudsley NHS Fdn Trust, Dept Psychiat, Kings Hlth Partners, London, England

[33] Sorbonne Nouvelle Univ, DR 178, ED 268, Paris, France

[34] Moroccan Soc Neurophysiol, Marrakech, Morocco

[35] Univ Med Sch Marrakech, Morocco & Basic & Clin Neurosci Res Lab, Marrakech, Morocco

[36] Complejo Hosp Pontevedra, Dept Neurol, Pontevedra, Spain

来源：

FRONTIERS IN NEUROLOGY | 2020年 / 11卷

关键词：

coronavirus disease 2019 (COVID-19); chronic neurological disease; healthcare services; guidelines; neurodegenerative disorders; protocols; pandemics; recommendations; MIGRAINE;

D O I：

10.3389/fneur.2020.00664

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

With the rapid pace and scale of the emerging coronavirus 2019 (COVID-19) pandemic, a growing body of evidence has shown a strong association of COVID-19 with pre- and post- neurological complications. This has necessitated the need to incorporate targeted neurological care for this subgroup of patients which warrants further reorganization of services, healthcare workforce, and ongoing management of chronic neurological cases. The social distancing and the shutdown imposed by several nations in the midst of COVID-19 have severely impacted the ongoing care, access and support of patients with chronic neurological conditions such as Multiple Sclerosis, Epilepsy, Neuromuscular Disorders, Migraine, Dementia, and Parkinson disease. There is a pressing need for governing bodies including national and international professional associations, health ministries and health institutions to harmonize policies, guidelines, and recommendations relating to the management of chronic neurological conditions. These harmonized guidelines should ensure patient continuity across the spectrum of hospital and community care including the well-being, safety, and mental health of the patients, their care partners and the health professionals involved. This article provides an in-depth analysis of the impact of COVID-19 on chronic neurological conditions and specific recommendations to minimize the potential harm to those at high risk.

引用

页数：13

共 95 条

[1] COVID 19 infection presenting as motor peripheral neuropathy [J].

Abdelnour, Loay ;

Abdalla, Mohammed Eltahir ;

Babiker, Saleem .

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (06) :1119-1120

[2]

ALS Association, 2020, COR DIS OUTBR COVID

[3]

American Academy of Neurology, 2020, POS STAT TEL

[4]

American Academy of Sleep Medicine, 2020, COVID 19 FAQS SLEEP

[5]

American Headache Society, 2020, COVID19 WORKFL HEAD

[6]

American Migraine Foundation, 2020, NAV MIGR HEAD TREATM

[7]

American Psychiatric Association, DIAGNOSTIC STAT MANU, V5th, DOI [10.1176/appi.books.9780890, DOI 10.1176/APPI.BOOKS.9780890]

[8]

[Anonymous], 2020, CORONAVIRUS CONTEXT

[9]

[Anonymous], ABSENCE ANY COMMERCI

[10]

[Anonymous], CONFLICT INTEREST AU

← 1 2 3 4 5 6 7 8 9 10 →